Article
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.
BMC Cancer
(2012)
Disciplines
Publication Date
Summer July 23, 2012
Citation Information
Michael Lock. "Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial." BMC Cancer (2012) Available at: http://works.bepress.com/michael_lock/6/